217 related articles for article (PubMed ID: 19449978)
1. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
2. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
Ribeiro D; Pinto JM
Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
[TBL] [Abstract][Full Text] [Related]
3. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
Nani FK; Oğuztöreli MN
IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
[TBL] [Abstract][Full Text] [Related]
4. Regression and regrowth of tumour cords following single-dose anticancer treatment.
Bertuzzi A; D'Onofrio A; Fasano A; Gandolfi A
Bull Math Biol; 2003 Sep; 65(5):903-31. PubMed ID: 12909255
[TBL] [Abstract][Full Text] [Related]
5. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.
Ribba B; Saut O; Colin T; Bresch D; Grenier E; Boissel JP
J Theor Biol; 2006 Dec; 243(4):532-41. PubMed ID: 16930628
[TBL] [Abstract][Full Text] [Related]
6. Cell resensitization after delivery of a cycle-specific anticancer drug and effect of dose splitting: learning from tumour cords.
Bertuzzi A; Fasano A; Gandolfi A; Sinisgalli C
J Theor Biol; 2007 Feb; 244(3):388-99. PubMed ID: 17074361
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear model predictive control for dosing daily anticancer agents using a novel saturating-rate cell-cycle model.
Florian JA; Eiseman JL; Parker RS
Comput Biol Med; 2008 Mar; 38(3):339-47. PubMed ID: 18222419
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
Shah MA; Schwartz GK
Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790
[TBL] [Abstract][Full Text] [Related]
9. A qualitative approach to cell growth modeling and simulation for cancer chemotherapy.
Gaglio S; Giacomini M; Nicolini C; Ruggiero C
IEEE Trans Biomed Eng; 1991 Apr; 38(4):386-9. PubMed ID: 1855803
[TBL] [Abstract][Full Text] [Related]
10. Towards whole-organ modelling of tumour growth.
Alarcón T; Byrne HM; Maini PK
Prog Biophys Mol Biol; 2004; 85(2-3):451-72. PubMed ID: 15142757
[TBL] [Abstract][Full Text] [Related]
11. Analysis of resonance chemotherapy in leukemia treatment via multi-staged population balance models.
Sherer E; Hannemann RE; Rundell A; Ramkrishna D
J Theor Biol; 2006 Jun; 240(4):648-61. PubMed ID: 16430925
[TBL] [Abstract][Full Text] [Related]
12. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
13. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
Iliadis A; Barbolosi D
Comput Biomed Res; 2000 Jun; 33(3):211-26. PubMed ID: 10860586
[TBL] [Abstract][Full Text] [Related]
14. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.
Clairambault J
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1054-68. PubMed ID: 17707544
[TBL] [Abstract][Full Text] [Related]
15. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
Boldrini JL; Costa MI
IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
[TBL] [Abstract][Full Text] [Related]
16. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
17. Mathematical modelling of the Warburg effect in tumour cords.
Astanin S; Preziosi L
J Theor Biol; 2009 Jun; 258(4):578-90. PubMed ID: 19232360
[TBL] [Abstract][Full Text] [Related]
18. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.
Altinok A; Lévi F; Goldbeter A
Eur J Pharm Sci; 2009 Jan; 36(1):20-38. PubMed ID: 19041394
[TBL] [Abstract][Full Text] [Related]
19. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
Barbarossa MV; Kuttler C; Zinsl J
Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
[TBL] [Abstract][Full Text] [Related]
20. A simple unforced oscillatory growth model in the chemostat.
Lemesle V; Gouzé JL
Bull Math Biol; 2008 Feb; 70(2):344-57. PubMed ID: 17912591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
